Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Pollard

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
JAMA Neurology|June 28, 2017
Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical TrialMichel Berg, Timothy E Welty, Barry E Gidal, et al.
The American Journal of Cardiology|August 6, 2002
Racial differences in the prevalence of cardiac sources of embolism in subjects with unexplained stroke or transient ischemic attack evaluated by transesophageal echocardiographyJorge R Kizer, Frank E Silvestry, Stephen E Kimmel, et al.
Science Translational Medicine|October 16, 2015
Glutamate imaging (GluCEST) lateralizes epileptic foci in nonlesional temporal lobe epilepsyKathryn Adamiak Davis, Ravi Prakash Reddy Nanga, Sandhitsu Das, et al.
Cell Reports|January 11, 2016
Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase ActivitiesKumar Sanjiv, Anna Hagenkort, José Manuel Calderón-Montaño, et al.
Journal of Medicinal Chemistry|March 19, 2011
Discovery of potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase as potential anticancer agentsJean-Damien Charrier, Steven J Durrant, Julian M C Golec, et al.
Oncotarget|July 11, 2014
Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970Amy B Hall, Dave Newsome, Yuxin Wang, et al.
Nature Communications|December 14, 2016
ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1AChris T Williamson, Rowan Miller, Helen N Pemberton, et al.
Epilepsia|October 6, 2017
Detection of generalized tonic-clonic seizures using surface electromyographic monitoringJonathan J Halford, Michael R Sperling, Dileep R Nair, et al.
Neurology|February 10, 2015
Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsyVicenta Salanova, Thomas Witt, Robert Worth, et al.
Nature Reviews. Clinical Oncology|June 2, 2016
Clinical development of new drug-radiotherapy combinationsRicky A Sharma, Ruth Plummer, Julie K Stock, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
JAMA Neurology|June 28, 2017
Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical TrialMichel Berg, Timothy E Welty, Barry E Gidal, et al.
The American Journal of Cardiology|August 6, 2002
Racial differences in the prevalence of cardiac sources of embolism in subjects with unexplained stroke or transient ischemic attack evaluated by transesophageal echocardiographyJorge R Kizer, Frank E Silvestry, Stephen E Kimmel, et al.
Science Translational Medicine|October 16, 2015
Glutamate imaging (GluCEST) lateralizes epileptic foci in nonlesional temporal lobe epilepsyKathryn Adamiak Davis, Ravi Prakash Reddy Nanga, Sandhitsu Das, et al.
Cell Reports|January 11, 2016
Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase ActivitiesKumar Sanjiv, Anna Hagenkort, José Manuel Calderón-Montaño, et al.
Journal of Medicinal Chemistry|March 19, 2011
Discovery of potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase as potential anticancer agentsJean-Damien Charrier, Steven J Durrant, Julian M C Golec, et al.
Oncotarget|July 11, 2014
Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970Amy B Hall, Dave Newsome, Yuxin Wang, et al.
Nature Communications|December 14, 2016
ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1AChris T Williamson, Rowan Miller, Helen N Pemberton, et al.
Epilepsia|October 6, 2017
Detection of generalized tonic-clonic seizures using surface electromyographic monitoringJonathan J Halford, Michael R Sperling, Dileep R Nair, et al.
Neurology|February 10, 2015
Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsyVicenta Salanova, Thomas Witt, Robert Worth, et al.
Nature Reviews. Clinical Oncology|June 2, 2016
Clinical development of new drug-radiotherapy combinationsRicky A Sharma, Ruth Plummer, Julie K Stock, et al.
Pageof 4